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Abstract

Introduction

As a cell source, multipotent mesenchymal stromal cells or
mesenchymal stem cells (MSCs) are promising candidates
for chondrogenic differentiation and subsequent cartilage
regeneration. From previous literature, it is known that
chondrogenic differentiation of MSCs inevitably leads to
hypertrophy and subsequent endochondral ossification. In
this review, we examine the history of currently established
protocols of chondrogenic differentiation and elaborate
on the roles of individual components of chondrogenic
differentiation medium. We also summarise the effects
of physical, chemical and biological factors involved,
and propose potential strategies to differentiate MSCs
into articular chondrocytes with homogenous mature
phenotypes through spatial-temporal incorporation of cell
differentiation and chondrogenesis.

Articular cartilage is an avascular connective tissue
with limited capacity for self-regeneration. Injury and
degeneration of cartilage have far-reaching impacts
on personal life, healthcare expenses and reduced
productivity in the work force (Ge et al., 2006).
Current clinical treatment strategies, such as autologous
chondrocyte implantation, bone marrow stimulation
and mosaicplasty, have varying success rates, but their
long-term results are far from satisfactory due to the lack
of structural organisation of articular cartilage, as well
as inferior mechanical properties of the newly formed
tissue (Hunziker, 2009). Cartilage tissue engineering
has the potential to create a more durable and functional
replacement for the degenerated tissue; chondrocytes
and stem cells are two promising cell source candidates
for this replacement tissue. Chondrocytes are potentially
the ideal seed cells with mature and stable phenotype as
well as lineage stability. However, they are limited by
scarcity during harvest and dedifferentiation during in
vitro proliferation (Kock et al., 2012). Establishment of
embryonic stem cells (ESCs) requires embryos, which
leads to ethical issues for clinical applications. Induced
pluripotent stem cell (iPSC) technology can provide
patient-specific cells, but uncontrolled and unexpected
differentiation limits their application (Blin et al., 2010;
Yoshida and Yamanaka, 2010). Multipotent mesenchymal
stromal cells or mesenchymal stem cells (MSCs) are a
broadly adopted cell source for cartilage regeneration due to
ample availability from multiple tissues, high proliferation
capacity and the ability to differentiate into chondrocytes
(Derfoul et al., 2006; Kassis et al., 2006). However,
concomitant premature phenotypes of the differentiated
chondrocytes, undesirable hypertrophic differentiation
(Studer et al., 2012), lack of subtype phenotypes and
subsequent immature extracellular matrix (ECM) under
current chondrogenic differentiation protocols have
hindered the clinical application of stem cell-differentiated
chondrocytes (Huey et al., 2012; Mueller and Tuan, 2008).
Weighing the advantages and disadvantages of candidate
cell sources, apart from using chondrocytes, MSCs may be
the most adaptive cell source for current clinical use and for
cartilage tissue engineering applications. Therefore, finding
ways to improve in vitro chondrogenic differentiation of
MSCs may be the next primary focus of tissue engineering
research, which is somewhat different with the well-
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orchestrated embryonic chondrogenic differentiation
process of MSCs. Embryonic chondrogenesis have been
reviewed extensively with the focus on mesenchymal cell
condensation, chondroprogenitor cells, chondrocytes as
well as related mediators (Goldring et al., 2006). Apart
from embryonic chondrogenesis, joint specification and
postnatal development have also been reviewed, though
many questions remain unexplored (Onyekwelu et al.,
2009). MSCs have been well studied, regarding their
definition, tissue origins, chemokines and receptors, as
well as their in vivo microenvironments (Augello et al.,
2010); key factors like cell metabolic activity and transcript
levels important for functional MSC-derived cartilage
regeneration are summarised elsewhere (Chen et al., 2006).
Based on all these progresses, we summarise the history
and challenges faced by current broadly used chondrogenic
differentiation protocols with an aim to shed valuable
light on the potential novel strategies to circumvent
the challenges faced, which may benefit bioengineers
and researchers in the field of tissue engineering and
regenerative medicine.

While articular cartilage at birth undergoes ossification
and mineralisation, appositional growth from the surface
forms an adult articular cartilage until puberty (Hunziker
et al., 2007; Onyekwelu et al., 2009). These slowly
dividing stem cells have bidirectional mitotic activity. In
the horizontal direction, they furnish new stem cells that
replenish the pool and contribute to the lateral expansion
of the articular cartilage layer. In the vertical direction,
the superficial zone supplies the rapidly dividing, transitamplifying daughter-cell pool that feeds the transitional
and upper radial zones and gradually forms the layered
structure (Hunziker et al., 2007). This growth activity of
the articular surface ceases at puberty, whereas expansion
of the metaphyseal growth plate continues until the time
of skeletal maturity (Clark et al., 1997; Hunziker et al.,
2007). Knowledge derived from endochondral ossification
has been largely used to establish current chondrogenic
differentiation protocols, while growth plate chondrocytes
that are easily accessible sources are often compared to
articular chondrocytes (Iwamoto et al., 2013; Leijten et
al., 2012) (Fig. 1).

Chondrogenic differentiation into articular
chondrocytes

A history of the understanding of chondrogenic
differentiation

Chondrogenesis is initiated by cell condensation during
embryonic development, before the mesenchymal
stem cells differentiate into multiple lineages, such as
articular, growth plate, intervertebral disc chondrocytes
or endochondral ossification [some of the cells survive
and transform into osteoblasts (Zhang et al., 2014)]. For
years, mesoderm was thought to be the origin of MSCs;
however, new evidence indicates that the neuroepithelium,
including the neural crest, may also be an early origin
of MSCs (Morikawa et al., 2009; Takashima et al.,
2007). MSCs from the somatopleure of the lateral plate
mesoderm, neural crest cells in the neural ectoderm and
sclerotome compartment of the paraxial mesoderm or
somite differentiate into chondrogenic lineages and then
yield the limbs, craniofacial bones and axial skeleton
separately (Goldring et al., 2006; Olsen et al., 2000).
Chondrogenesis may occur in one of two directions in the
developing bone. One leads to the formation of bone via
endochondral ossification, (at the primary and secondary
centres of ossification, and in the growth plate) and the
other leads to stable hyaline articular cartilage. The growth
plate is composed of the resting zone, proliferative zone
and hypertrophic zone (Abad et al., 2002). Growth plate
cartilage progresses to form the bone (Mackie et al.,
2008), whereas the articular cartilage does not (Pacifici
et al., 2005). Chondrocytes of the presumptive articular
surface arise directly from a subpopulation of early
chondroprogenitor cells, expressing doublecortin and
growth/differentiation factor-5 (GDF-5) (Koyama et al.,
2008; Zhang et al., 2007), but not matrilin-1 (Hyde et al.,
2007). Articular chondrocytes maintain the phenotype
instead of resorting to hypertrophy by maintaining high
expression of ACAN and PRG4 (lubricin gene) and low
expression of COL2A1 with low proliferation (Lefebvre
and Smits, 2005).

Studies of the embryonic development of cartilage or
cartilaginous tissues started as early as the 1960s. Ectopic
implantation was a major research model during this
period. The somites, which are embryonic cartilaginous
progenitor cells, differentiated into chondrocytes in vitro
when co-cultured with notochords (Lash et al., 1960).
Holtzer observed chondrogenesis of somites occurring
in the presence of neural tubes (Holtzer, 1952; Holtzer
and Detwiler, 1953). A fraction obtained from a cold
perchloric acid extract of spinal cord and notochord was
able to induce chondrogenesis (Lash et al., 1962), which
contained chondrogenic factors consisting of polypeptides,
nucleotides and sugars (Holtzer, 1964; Hommes et al.,
1962). De-differentiation of chondrocytes was reported
with morphological changes from spherical to stellate
coupled with decreased synthesis of chondroitin sulphate
and enhanced cell proliferation (Abbott and Holtzer, 1966).
These findings led to the establishment of the pellet culture
system, now broadly used in chondrogenic differentiation
(Hattori and Ide, 1984).
In the 1970s and 1980s, laboratory studies evaluating
the effect of cell shape, cell-cell and cell-matrix interactions
on chondrogenesis were undertaken. Chondrocytes
with spherical morphologies synthesised higher levels
of chondroitin sulphate in comparison to those with
spindle-like morphologies (Archer et al., 1982). Cellcell interactions, including both interactions amongst
limb bud mesenchyme cells (Owens and Solursh, 1982)
and epithelial-mesenchymal cells (Sanders, 1988), are
essential for the differentiation of prechondrogenic limb
mesenchyme into cartilage. Gene expression of both COL
I and fibronectin increased at the onset of condensation,
reached the highest point of chondrogenic differentiation
and then subsided and were replaced with elevated
COL2A1 expression (Dessau et al., 1980; Kulyk et al.,
13
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Fig. 1. A schematic representation of different stages of chondrogenesis and endochondral ossification. The
development of cartilage starts with MSC condensation. After committing to chondrogenesis, cells follow one of
two different directions in the developing bone. One leads to the formation of bone via endochondral ossification
(at the primary ossification centre (POC), secondary ossification centre (SOC), and in the growth plate) (the process
marked in black) and the other that leads to stable hyaline articular cartilage. All committed hyaline chondrocytes
start expressing COL2A1; matrilin-1 expression by cells arising from the interzones that are destined to become
growth plate chondrocytes distinguishes them from articular chondrocytes. Doublecortin and GDF-5 only express in
the articular cartilage. Most embryonic articular cartilage present at the ends of the bone at birth is replaced by bone
and new cartilage formed by stem cells in the superficial zone. Articular cartilage becomes fully mature in adulthood.
With the disappearance of growth plate cartilage, the SOC connects with the POC and gradually disappears in mature
mammals. Stem-like cells exist in the cell condensation stage, keep stemness in the superficial zone of AC from birth
until puberty, and exist in the form of resting stem-like cell after adulthood.

1989). Furthermore, in the 1980s, transforming growth
factor-β (TGF-β) was identified as a key cartilage-inducing
factor (Heine et al., 1987; Seyedin et al., 1986).
Many components play supplementary roles in
the current chondrogenic differentiation medium. For
instance, ascorbate stabilises the triple helical structures
of collagen through hydroxylation of proline residues
in procollagen and hydroxyproline (Peterkofsky, 1972).
Serum inhibits the production of cartilage matrix during
in vitro chondrogenesis of limb bud mesodermal cells of
chick embryos (Hattori and Ide, 1984), whereas serumfree medium containing insulin/transferrin/selenium (ITS)
successfully keeps cells alive and active (Bottenstein and
Sato, 1979).
The current broadly-used chondrogenic differentiation
medium was established in the 1990s, with the presence
of TGF-β in pellet cultures (Johnstone et al., 1998). This
chondrogenic differentiation medium includes TGF-β,
ITS, high-glucose, dexamethasone (Dex), ascorbic acid,
sodium pyruvate and proline, but lacks serum (Johnstone
et al., 1998; Vater et al., 2011) (Table 1). High-glucose
was found to promote MSC survival and protect cells from
apoptosis by altering the metabolism of the cells in pellet
cultures and increasing the synthesis of proteoglycans
through respiratory repression (Crabtree effect) (Mackay
et al., 1998).
The functions and mechanisms of differentiationrelated growth factors, such as bone morphogenetic
protein (BMP), fibroblast growth factor (FGF), parathyroid
hormone related protein (PTHrP) and Indian hedgehog
(IHh), were studied in depth during this period (Murtaugh
et al., 1999; Shukunami et al., 1996). Though these
growth factors can benefit chondrogenesis in vitro, they
are not routinely included in the current medium due to

several limitations. BMPs have been shown to promote
the expression of SOX9 and COL II, however, they also
inevitably result in a hypertrophic phenotype of cells
(Enomoto-Iwamoto et al., 1998; Nonaka et al., 1999).
FGFs can maintain the proliferation of cells but result in
chondrodysplasia when overexpressed (Minowada et al.,
1999). Additionally, PTHrP can reverse chondrocytes from
a hypertrophic phenotype to a prehypertrophic proliferating
phenotype, and prevent terminal differentiation of
chondrocytes in vitro (Zerega et al., 1999). IHh expressed
in prehypertrophic chondrocytes enhances hypertrophic
differentiation. Misexpression of IHh can prevent
hypertrophic differentiation of chondrocytes (Vortkamp
A, 1996).
In the late 1990s, the role of integrins in mediating
cell attachment to extracellular matrix proteins was
highlighted. These interactions regulated morphogenesis
and cell differentiation. Treatment with integrin β1
antibodies inhibited early chondrogenesis of limb bud
cells from mouse embryos in vitro (Shakibaei, 1998).
Additionally, SOX9 was found to be a master gene which
regulated downstream COL2A1 expression directly (Healy
et al., 1999).
Understanding of chondrogenic differentiation has
accelerated since the year 2000, attributed to the application
of a variety of genetic modification techniques. Epigenetics
then emerged as an important field. MicroRNAs (miRNAs)
proved effective mediators of key pathways during
MSC differentiation through regulating transcription
factors (Hong and Reddi, 2012). DNA methylation and
histone modification (including histone acetylation and
deacetylation) are involved in chondrogenesis through
modulating chromatin structures, which directly influence
the activity of DNA in transcription, replication and
14

www.ecmjournal.org

X Tang et al.

Optimising chondrogenic differentiation

Table 1. Chondrogenic differentiation medium and effects of individual components on chondrogenesis
Factors

Function

TGF-β (J.Zuscik et
al., 2004; Lutz and
Knaus, 2002; Park et
al., 2011; Schmierer
and Hill, 2007)

Promotes
chondrogenesis,
enhances extracellular MAPK, Wnt,
matrix production
β-catenin, Smad
and downregulates
collagen I expression

Insulin (Mueller et al., Stimulates collagen
2013; Quarto et al.,
synthesis, inhibits
1992)
hypertrophy

The well-established
chondrogenic
differentiation serumfree media
(Johnstone et al., 1998;
Vater et al., 2011)

Signalling

Dose

Synergy

10 ng/mL

IGF-I, BMPs, TGF-β1, β2 and β3, have similar
PHTrP
functions

Enhances tyrosine
kinase activity of
1-10 μg/mL
the insulin receptor

Transferrin,
selenium

Transferrin (Cigan,
2013; Kisiday et al.,
2005)

Iron-binding

1-30 μg/mL

Insulin,
selenium

Selenium (Yan et al.,
2012)

Anti-oxidant and
enhances proliferation

5 μg/mL

Insulin,
transferrin

Dex (M.Florine et
al., 2013; Thomas
M.Randua, 2013)

Supports cell viability
and delays the
GRs, Scrapie
-7
M
appearance of type X Responsive Gene 1 10
collagen

Glucose (Cigan, 2013;
Han et al., 2004; Tsai,
2013)

Major energy
source, precursor
for the synthesis of
glycosaminoglycans

PKCα, p38MAPK, 4.5
g/L
ERK

Ascorbic acid (Choi et
al., 2008; Franceschi,
1992; Peterkofsky,
1972; Stone and
Meister, 1962)

Proliferation, DNA
synthesis, collagen
biosynthesis and
reductant

Reduction of iron
to its ferrous state

Pyruvate (Andrae et
al., 1985; Geshi et al.,
2000)

Energy source,
against hydrogen
peroxide-induced
cytotoxicity

Proline (Peterkofsky,
1972; Washington et
al., 2010)

Stabilisation of
the collagen triple
helix，promotes ES
cell differentiation

50 mg/mL

Subtypes

TGF-β

Proline

L-ascorbate, sodium L-ascorbate,
and L-ascorbate-2-phosphate

1 mM

mTOR signalling
pathway

40 μg/mL

Ascorbic acid
BMP-2, enhances proliferation and
ECM, and downregulates Col I
expression.
BMP-4, accelerates the progression
of cartilage differentiation to
maturation
BMP-6, enhances chondrogenesis
in special subpopulation of MSCs,
increases proteoglycans
BMP-7, inhibits cell proliferation,
induces chondrogenic
differentiation
BMP-9, enhances Sox9, Col2A1
and aggrecan, overcome the
inhibitory effect of IL-1.
GDF-6(BMP-13), inhibits
hypertrophic chondrocyte specific
marker, upregulate of proteoglycan

BMPs (Cao and Chen,
2005; Hassel et al.,
2003; Hatakeyama
et al., 2004; Jin et
al., 2006; Sekiya et
al., 2005; Shen et al.,
2010)

Enhances cartilage
formation

MAPK, Wnt,
Smad

10-500 ng/mL TGF-β

GDF-5(BMP-14)
(Coleman and Tuan,
2003; Hatakeyama et
al., 2004)

Enhances cell
condensation,
chondrogenesis, and
ECM production

Gap junction
intercellular
communication,
p38MAPK

150 ng/mL

TGF-β, BMP

PHTrP (Barbara
Zerega, 1999; Kim et
al., 2008; Mau et al.,
2007)

Inhibits the TGF-βinduced hypertrophic
differentiation

PTHrP and IHH
feedback loop

10 μM

TGF-β

PHTrP1-34

FGF (Ng et al., 2008;
Solchaga et al., 2005;
Tsutsumi et al., 2001)

Regulates
proliferation,
and increases
cartilaginous ECM
production

ERK

10 ng/mL
FGF-2
10-9 M FGF18

TGF-β

FGF-2, increases proliferation, and
proteoglycan production
FGF-18, inhibits cell proliferation
and induces chondrogenic
differentiation

Selected growth
factors regulators

recombination (Furumatsu and Ozaki, 2010; Roth et
al., 2001). Recently, several groups found an important
relationship between epigenetic marking and gene
expression in chondrogenesis. Herlofsen et al. found that
modifications can provide primary epigenetic control of
the early differentiation of MSCs toward the chondrogenic
lineage (Herlofsen et al., 2013).
Biophysical, chemical and mechanical factors were
found to be heavily involved in chondrogenesis (Leijten et
al., 2014). Small chemical molecules (Benoit et al., 2008),
matrix elasticity (Engler et al., 2006; Park et al., 2011), cell
material property (cell softness) (Chowdhury et al., 2010)
and many more factors, are now known to guide MSCs
to differentiate into specific cell lineages. A breakthrough

in the regeneration of articular cartilage illustrated that an
entire articular surface can be regenerated using adult stem/
progenitor cells recruited from the host with the help of
biomaterial-based scaffold and growth factors (Lee et al.,
2010).
Key elements in current chondrogenic differentiation
medium
At present, MSCs cultured in pellet and micromass systems
in the presence of chondrogenic differentiation medium
are the two major methods for initiating chondrogenic
differentiation in vitro. The following sections will describe
15
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Fig. 2. TGF-β and MAPK
signalling in chondrogenic
differentiation of MSCs.

signalling, the major subtypes of MAPK include p38,
extracellular signal-regulated kinase-1 (ERK-1) and c-jun
N-terminal kinase (JNK). In addition, p38 is an enhancer
of chondrogenesis, whereas ERK-1 is a repressor of
chondrogenesis; JNK plays a minor role in chondrogenesis.
Activation of MAPK involves indirect modulation of cell
adhesion molecules, including N-cadherin and integrin
α5β1, during precartilage condensation and progression
to chondrogenic differentiation (Tuli et al., 2003). TGF-β
induces the expression of the chondrogenic factor SOX9
and the function of the main chondrogenic trio (SOX5,
SOX6 and SOX9) (Lefebvre et al., 1998; Lefebvre
and Smits, 2005) that further regulates chondrogenic
differentiation and ECM formation. It is known that the
genes for many ECM components, such as ACAN, COL2A1
and Matrilin-1, are only expressed when the three Sox
proteins bind to the high-mobility group (HMG)-domain
sites in their enhancers (Akiyama and Lefebvre, 2011).
On the contrary, TGF-β also plays an inhibitory role in
chondrocyte maturation (Ballock et al., 1993; Kato et al.,
1988; Serra et al., 1997).
ITS premix is a substitute for foetal bovine serum
that maintains cellular activity in biosynthesis and cell
division. Serum has some disadvantages including poor
characterisation and inconsistency in batch-to-batch
composition and quality (Barnes and Sato, 1980; Cigan,
2013). Insulin is a primary factor involved in the onset
and progression of chondrogenesis (Quarto et al., 1992)
and can facilitate chondrogenesis in a dose-dependent
manner (1-10 μg/mL) with added TGF-β (Mueller et al.,

the in-depth role of the ingredients potentially used in
chondrogenic differentiation medium.
TGF-β is the core component in most chondrogenic
differentiation protocols used currently. TGF-βs exist in
three homologous homodimeric forms (β1, β2 and β3)
and all of them signal through the same receptors [TGF-β
receptor I (TGF-β RI) and II (TGF-β RII)]. After activation
of the TGF-β receptors, TGF-β induces chondrogenesis
mainly through TGF-β/drosophila mothers against
decapentaplegic protein (Smad) and mitogen-activated
protein kinase (MAPK) signalling pathways, that cross-talk
with each other (Li et al., 2010; Lutz and Knaus, 2002;
Schmierer and Hill, 2007) (Fig. 2). Before phosphorylation
by TGF-β RII, TGF-β RI is catalytically inactive due to
a wedge-shaped GS region (a highly conserved 30-amino
acid region with a characteristic SGSGSG sequence)
inserted into the kinase domain (Massagué, 1998). In Smad
signalling, TGF-β RII phosphorylates the GS region after
forming a ligand-receptor complex with TGF-β, which
results in the activation of TGF-β RI (Huse et al., 1999).
The activated TGF-β RI phosphorylates Smad2/3, which
recruits Smad4, and the complex translocates into the
nucleus (Massagué and Wotton, 2000). The translocated
Smad2/3 associates with Sox9 and CBP/p300 (cAMPresponse element-binding protein, which has an intrinsic
histone acetyltransferase activity and acts as an important
co-activator for the expression of the COL2A1) on the
COL II enhancer region containing the Sox9-binding
site that is important for the initiation of chondrogenic
differentiation (Furumatsu et al., 2005). As for MAPK
16
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2013a). Furthermore, insulin can facilitate glucose uptake
(Kono et al., 1982) and enhance DNA synthesis and
proteoglycan production in cartilage cultures (Maor et al.,
1993; Rosen, 1987). Transferrin promotes cell proliferation
and differentiation through detoxifying oxygen radicals
and peroxides (Ned et al., 2003; Schäfer et al., 2007).
Selenite, a co-factor for glutathione peroxidase and other
proteins, enhances proliferation of chondrocytes through
acceleration of G1-phase cell cycle progression and the
induction of cyclin D1 (Wei et al., 1986). This effect is
mediated by the enhancement of intracellular adenosine
triphosphate (ATP) content (Yan et al., 2012).
Dex, a synthetic glucocorticoid, promotes chondrogenic
differentiation through enhancing related gene expression
(Florine et al., 2013; Jakobsen et al., 2014; Randua et al.,
2013). The chondrogenic effects of glucocorticoids are
predominantly mediated via the glucocorticoid receptors
(GRs). GRα constitutes the main active GR form while
GRβ constitutes a negative isoform of GRα (Oakley et
al., 1999). Dex promotes chondrogenic differentiation by
down-regulating GRβ levels and maintaining GRα levels
(Derfoul et al., 2006). Dex enhances the gene expression
of COL XI under chondrogenic conditions (collagen XI
acts as both the template for collagen II fibrillogenesis and
a regulator for maintaining fibril diameters in cartilage)
(Chen et al., 2005; Derfoul et al., 2006). Previous studies
have shown that Dex enhanced the TGF-β induced
expression of ACAN, COL2A1 and cartilage oligomeric
matrix protein (COMP) and supported cell viability, as
well as delayed the expression of COL X when used in
conjunction with TGF-β (Derfoul et al., 2006; Quarto et al.,
1992). The tissue origin of MSCs determines the effect of
Dex on chondrogenic differentiation. Dex enhanced TGFβ1-induced chondrogenesis in bone marrow-derived MSCs
(BMSCs) but had no significant impact on the TGF-β1- or
BMP2-induced response in synovial derived MSCs (Kurth
et al., 2007; Park et al., 2005; Shintani and Hunziker, 2011;
Shintani et al., 2007). This may be due to the different
cell survival rates and microenvironment which could be
tissue-source dependent (Buxton et al., 2011).
Glucose, a major energy source and precursor of
ECM for most mammalian cells, promotes chondrogenic
differentiation and inhibits apoptosis at high levels
(4.5 g/L or 25 mM) (Mackay et al., 1998; Shikhman
et al., 2001; Tsai et al., 2013). Glucose participates in
multiple metabolic cycles of MSCs during chondrogenic
differentiation, including oxygen consumption, glucose
consumption and lactate production. High levels of
glucose in the medium enhance cell differentiation
by changing the metabolic patterns and modulating
subsequent cell signalling pathways. The synthesis of
proteoglycans increases through progressively inhibiting
the respiration of chondrocytes cultured in vitro, as the
glucose concentrations (1-10 mM) increase (Derfoul et
al., 2006; Otte, 1991). High doses of glucose enhance the
differentiation of stem cells into chondrogenic lineages
through the down-regulation of ERK and protein kinase C α
(PKCα) activities, up-regulation of p38, as well as through
modulating the expression of adhesion molecules such as
fibronectin, integrin β1 and N-cadherin (Han et al., 2004).
Both ascorbic acid and proline are essential for the

production of collagen in cartilage. Ascorbic acid enhances
cell proliferation, synthesis and extracellular deposition of
collagenous matrix, in particular collagen I and II (Choi
et al., 2008; Franceschi, 1992; Potdar and D’Souza, 2010;
Stone and Meister, 1962). Ascorbic acid stabilises the
collagen triple helical structure through reduction of iron
to its ferrous state, which is important for the hydroxylation
of proline residues in procollagen and hydroxyproline and
the maturation of protocollagen to collagen (Padh, 1991;
Peterkofsky, 1991). Proline has been shown to regulate
ESC differentiation into early primitive ectoderm-like
(EPL) cells, through mammalian targeting of the rapamycin
(mTOR) signalling pathway (Washington et al., 2010).
Sodium pyruvate is essential for enhancing the energy
metabolism in the Krebs cycle (Geshi et al., 2000).
Mammalian cells secrete pyruvate and α-ketoacids in
culture to protect them against hydrogen peroxide-induced
cytotoxicity (Andrae et al., 1985; O’Donnell-Tormey
et al., 1987). Pyruvate up-regulates the expression
of genes involved in free radical scavenging which,
in turn, enhances the antioxidative machinery and is
essential for maintaining mitochondrial activity. Superphysiological concentrations of pyruvate (50 mM, 50 folds
of physiological concentrations) enhance mitochondrial
mass and functionality (Wilson et al., 2007).
Phenol red, a commonly used pH indicator in tissue
culture medium can inhibit the chondrogenic differentiation
of MSCs (Lysdahl et al., 2013). During chondrogenic
differentiation, phenol red in Dulbecco’s Modified Eagle
Medium (DMEM) has been shown to decrease SOX9,
COL2A1 and ACAN on days 14 and 21 and proteoglycan
synthesis on days 21 and 28 in culture (Lysdahl et al.,
2013). This phenomenon may have occurred due to
phenol red’s structural resemblance to certain nonsteroidal
oestrogens and weak oestrogen agonist activity (Berthois
et al., 1986).
BMPs are morphogens in the TGF-β superfamily and
regulate chondrogenesis and skeletogenesis during normal
embryonic development (Hogan, 1996). They are involved
in various stages of chondrogenic differentiation, from
initiation of chondrogenic differentiation, to regulation
of chondrocyte maturation and terminal differentiation
(Pizette and Niswander, 2000). BMP2, BMP4, BMP6
and BMP7 are the most commonly used BMPs for
chondrogenic differentiation (Kramer et al., 2000; Sekiya
et al., 2005; Shen et al., 2010). BMPs signal through Smad
or non-Smad signalling pathways. The Smad1/5/8 route
is an important Smad-dependent pathway that induces
hypertrophy and bone formation (Cao and Chen, 2005).
The alternative Smad-independent pathway in BMP
regulates chondrogenesis, mediated by activating several
MAPKs including ERKs and p38 kinases (Hassel et al.,
2003). p38 enhances chondrogenesis by up-regulating
SOX9 expression directly or by inhibiting the Wnt7a/
beta catenin pathway indirectly (Jin et al., 2006). MSCs
from different species and tissue sources vary in their
responsiveness to BMPs, partly due to their distinct cell
receptor repertoires (Hennig et al., 2007; Osyczka et al.,
2004).
GDF5, also known as BMP14 in humans, is a
member of the TGF-β superfamily and plays an important
17
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culture MSCs, but in differentiation medium, it may not
be necessary.

role in limb bud mesenchymal cell condensation and
chondrogenesis during embryogenesis (Coleman and Tuan,
2003; Storm et al., 1994). GDF5 stimulates the recruitment
and differentiation of chondrogenic cells at early stages
and increases chondroprogenitor cell condensation and
cartilaginous nodules without altering the overall pattern
of differentiation. It causes a more sustained elevated
expression level of SOX9 than BMP4 (Hatakeyama et al.,
2004). GDF5 increases mesenchymal cell condensation
independent of cell density or N-cadherin-mediated
adhesion and signalling; however, it is dependent on gap
junction-mediated cellular communication (Coleman
and Tuan, 2003; Sun et al., 2012). GDF5 can promote
chondrogenesis via signalling cross-talk, when used
together with TGF-β3 and BMP2 in vitro (Murphy et
al., 2015). GDF5 has also been shown to increase the
expression of COL2A1 and hypertrophic marker, alkaline
phosphatase (ALP) by enhancing the phosphorylation of
Smad1/5/8 (Coleman et al., 2013), which is activated by
BMPs. GDF5’s effect on the enhancement of ACAN and the
inhibition of MMP13 expression occurs by up-regulating
the canonical Wnt inhibitors DKK1 (Enochson et al.,
2014).
PTHrP inhibits TGF-β-induced hypertrophic
differentiation by up-regulating the chondrogenic
markers COL2A1 and SOX9 and down-regulating the
hypertrophic markers COL10A1 and RUNX2 during in
vitro chondrogenesis of MSCs (Kim et al., 2008; Weiss et
al., 2010). PTHrP exerts its effects in vivo via the PTHrP
and IHh feedback loop by binding to its receptor (PTHR1)
and activating a range of signalling molecules, e.g. protein
kinase A (PKA), PKC and inositol 1, 4, 5-tris-phosphate
(IP3). Some signalling molecules act as negative regulators
for IHh. Hence, PTHrP inhibits the terminal differentiation
of chondrocytes driven by IHh (Kim et al., 2008; Mau et
al., 2007; Rabie et al., 2003). The chondrogenic effects
of PTHrP vary amongst different PTHrP isoforms. PTHrP
1-34, added in chondrogenic medium containing TGF-β3,
significantly increases chondrogenic differentiation with
less hypertrophic differentiation, while other isoforms
(PTHrP 1-86, 7-34 and 107-139) show inconsistent
effects (Lee and Im, 2012). When culturing MSC pellets
under hypertrophy-enhancing conditions [hypertrophyenhancing medium consisting of DMEM, 1 % ITS, 50 μg/
mL ascorbate-2-phosphate, 40 μg/mL L-proline and 1 nM
triiodothyronine (T3)], adding PTHrP (1-40) does not
diminish the induced enhancement of hypertrophy (Mueller
et al., 2013b).
The FGF family, especially FGF [basic FGF (bFGF);
also known as FGF2], can maintain MSCs in an immature
state during in vitro expansion and enhance MSC
proliferation and differentiation potential (Mastrogiacomo
et al., 2001; Solchaga et al., 2005; Tsutsumi et al., 2001).
Literature suggests that aggregates of human MSCs that
were expanded in culture in the presence of bFGF lacked
the collagen I-positive and collagen II-negative outer layer
characteristics of aggregates (Ng et al., 2008; Solchaga
et al., 2005). However, in pellet cultures, the prolonged
exposure of MSCs to bFGF caused the reduction of
glycosaminoglycan (GAG) production (Hellingman et al.,
2010). Therefore, bFGFs can be added into the medium to

Physical, chemical and biological factors
In addition to biochemical molecules used in current
chondrogenic differentiation medium, many other factors
are involved in chondrogenic differentiation. These
factors include physical (oxygen tension, mechanical,
topography, etc.), chemical (small molecules, chemical
properties, etc.) and biological factors (gene modification,
bioactivity, epigenetics, etc.). Apart from biochemical
factors (growth factors), biophysical factors (co-culture)
and biophysicochemical factors (biomaterials) are equally
important (Fig. 3). The influence of biophysical factors on
chondrogenesis in vivo and in vitro have been reviewed
(Huang et al., 2010a; Studer et al., 2012; Tate et al., 2008).
In this section, we focus on the use of biophysical and
biochemical cues for chondrogenesis and recent advances
in the field of tissue engineering.
Hypoxia can facilitate chondrogenic differentiation
of MSCs, in addition to maintaining an undifferentiated
state and inducing apoptosis. The microenvironment or the
niche of MSCs in the bone marrow has low oxygen tension
(˂ 32 mm Hg, 4.2 % oxygen) (Oze et al., 2012; Spencer
et al., 2014). Therefore, chondrogenic differentiation
is enhanced when MSCs are cultured in hypoxia (5 %
oxygen) in comparison to normoxia (20 % oxygen)
(Lee et al., 2013). Hypoxia has a positive influence on
chondrogenic differentiation of MSCs, mainly through
phosphorylation of AKT (known as protein kinase B) and
p38 MAPK, thereby down-regulating hypoxia-inducible
factor (HIF-1) (Kanichai et al., 2008).
Mechanical stimulation can directly influence the fate of
undifferentiated stem cells (Estes et al., 2004) via cellular
and nuclear deformation and indirect biophysical factors,
including osmotic and hydrostatic pressure and fluid
flow (O’Conor et al., 2013). Matrix elasticity directs the
differentiation of stem cells; soft matrix (~ 1 kPa) has been
shown to promote MSC differentiation into a chondrogenic
lineage (Engler et al., 2006; Park et al., 2011), while
activation and internalisation of integrin are actively
involved in the regulation of stem cell differentiation (Du
et al., 2011). Cell-material properties, such as cell stiffness,
dictate cell spreading and alter differentiation in response
to physical stimuli (Chowdhury et al., 2010). Surface
topography can trigger changes in MSC morphology, gene
expression and cytoskeletal structure (Huang et al., 2010b).
Compared to non-patterned surfaces, nano-pillar and
nano-hole topographies enhanced MSC chondrogenesis
and facilitated hyaline cartilage formation, whereas nanogrill topography delayed chondrogenesis and induced the
formation of fibro/superficial zone cartilage (Wu et al.,
2014).
Small chemical molecules are also known to guide MSC
differentiation (Benoit et al., 2008) by binding to specific
receptors that promote chondrogenic differentiation
(Cho et al., 2012; Johnson et al., 2012; Kafienah et al.,
2007; Schugar et al., 2008). As an illustrative example,
kartogenin (KGN) has been shown to encourage
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Fig. 3. Factors in the process of in vitro chondrogenic differentiation in MSCs.

chondrogenic differentiation of human MSCs, by
significantly enhancing the expression of COL2A1, SOX9
and ACAN. However, KGN had no significant effect on the
gene products associated with chondrocyte calcification,
such as osteocalcin (OCN), ALP and COL10A1, in human
MSCs or chondrocytes (Johnson et al., 2012). KGN
functions by binding to filamin A, an actin-binding protein
that cross-links actin filaments. Thereby, by regulating the
cytoskeletal network organisation and dynamics (Gorlin et
al., 1990) and disrupting its interaction with core binding
factor β (CBFβ), it modulates the activity of the RUNX
family of transcription factors (Johnson et al., 2012).
Small molecule inhibitors can regulate chondrogenesis
by blocking key receptors or signalling pathways. As
a nuclear receptor, retinoic acid receptor β (RARβ) is
down-regulated significantly during chondrogenesis. The
synthetic inhibitor (LE135) enhances chondrogenesis while
inhibiting hypertrophic differentiation (Kafienah et al.,
2007). Another small molecule inhibitor, dorsomorphin,
can block Smad1/5/8 signalling, enhance chondrogenesis,
elevate the production of collagen II and prevent
mineralisation (Hellingman et al., 2011; Retting et al.,
2009). Inhibition of inflammatory factors can boost
the chondrogenic differentiation capacity of MSCs
obtained from osteoarthritis patients through inhibiting
inflammatory stimuli-induced damage, hypertrophy and
apoptosis (Murphy et al., 2002; Rainbow et al., 2013).
Using a gene transfer/silencing strategy on MSCs can
facilitate change in the complex regulatory networks of
stem cell biology and regulate chondrogenic differentiation
processes (Feng et al., 2008; Paik et al., 2012). For example,

knockdown of HIF-1α by HIF-1α small interfering RNA
(siRNA) leads to an increase in chondrogenesis (Kanichai
et al., 2008).
Biomaterials can facilitate chondrogenesis in multiple
ways, including mechanical support, surface topography
and stiffness, chemical modification and bioactivity (Bian
et al., 2013; Lutolf et al., 2009; Wise et al., 2009; Zhang
et al., 2014). Co-cultures of chondrocytes and MSCs
enhance chondrogenesis due to the trophic role of MSCs
(MSCs secrete a variety of cytokines and growth factors
that have both paracrine and autocrine activities), which
stimulate chondrocyte proliferation and matrix production.
However, MSCs in co-culture conditions do not actively
undergo chondrogenic differentiation themselves (Caplan
and Dennis, 2006; Meretoja et al., 2012; Wu et al., 2012).
Future Perspectives
Heterogeneous differentiation of differentiated MSCs is
one of the main challenges faced in in vitro chondrogenic
induction and is seldom discussed. Multiple factors are
involved in these processes, such as variance in cell-cell
and cell-matrix adhesions, autocrine or paracrine activities,
different subpopulations of MSCs used, individual
cells encapsulated in biomaterials that induces different
cellular microenvironments (such as exchange of nutrient
and waste, oxygen gradients), etc.. High-throughput
technologies, such as microfluidics or microfabrication,
may be able to set up large scale production of homogeneous
microtissues or microenvironments to circumvent this issue
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(Jakobsen et al., 2014). Assembling pellets containing
varying sub-phenotypes of differentiated chondrocytes
layer-by-layer has previously been shown to mimic the
structural properties of articular cartilage (Chen et al.,
2006). Defining subpopulations of MSCs may provide a
good foundation; some progress in this field has been made
(Houlihan et al., 2012). As cells only differentiate when
they exit the cell cycle, fine-tuned cell cycles at the initial
stages of differentiation can influence cells to differentiate
into homogeneous phenotypes (Li et al., 2014).
Senescence and apoptosis inherently occur during
both embryonic development and in vitro chondrogenic
differentiation, so regulation of these two processes
could potentially regulate chondrogenic differentiation.
Senescence and apoptosis synergistically prevent the
over-growth of chondrocytes and shapes the articular
cartilage during embryonic development (Ito and Kida,
2000; Loeser, 2009). Senescence of bone marrow MSCs
is associated with low proliferation activity and decline
of stemness (Squillaro et al., 2015), which may lead to
inferior chondrogenic differentiation efficiency (Vacanti
et al., 2005). Efforts in hampering cell senescence during
chondrogenic differentiation with growth factors, antiinflammatory drugs, antioxidants, nutrients as well as
appropriate microenvironments such as hypoxia and
stem cell matrices effectively improve the efficiency and
quality of tissue-engineered cartilage in vitro and in vivo
(Li and Pei, 2012; Rainbow et al., 2013). It is known that
the majority of cells in pellet cultures undergo apoptosis
(Wang et al., 2010). Apoptosis may occur due to low
nutrient supply to cells in the centre of the pellet, hypoxia
and subsequent cell fate. Some preconditioning steps,
such as use of medium with high glucose, and hypoxia
preconditioning, may be able to protect MSCs from
undergoing the process of apoptosis (Mackay et al., 1998;
Wang et al., 2008).
In addition, biophysical signals are indispensable
for successful chondrogenic differentiation. Mechanical
properties influence phenotypes of differentiated
chondrocytes and affect respective progenies (Yang
et al., 2014). Oxygen tension or hypoxia can facilitate
differentiation. MSCs can differentiate into hyaline cartilage
chondrocytes instead of hypertrophic chondrocytes which
is more likely to happen under current chondrogenic
differentiation protocols (Leijten et al., 2014). Premature
and unstable phenotypes of differentiated chondrocytes
pose challenges for potential clinical use and lead to
inferior quality of regenerated cartilage (Pelttari et
al., 2006). Mimicking embryonic articular cartilage
formation instead of embryonic chondrogenesis can
assist bioengineers in overcoming this challenge, which
means that temporal regulation of multiple factors may
be required. For example, decreased Wnt, hedgehog and
BMP signalling and specification of GDF-5 expression
are of great importance for the homeostasis of articular
chondrocytes (Bobacz et al., 2008; Leijten et al., 2012).
Previous studies have shown that over expression of
GDF-5 led to the unsuccessful differentiation of articular
chondrocytes (Feng et al., 2008). However, the role of GDF5 in embryonic arthrogenesis and postnatal development
is not entirely clear. From our viewpoint, hypertrophy

will not pose challenges to chondrogenic differentiation
if optimised protocols can further differentiate stem cells
into articular chondrocytes and maintain their classic
phenotypes.
Temporally fine-tuning chondrogenic differentiation
medium can profoundly enhance differentiation efficiency.
Chondrogenic differentiation medium is involved in
administering TGF-β and other factors throughout
the entire culture period (Johnstone et al., 1998).
Previously, multiple factors induced step-wise mesoderm
differentiation and subsequent chondrogenesis through
mimicking embryonic chondrogenesis (Oldershaw et al.,
2010). The sequential addition of growth factors may be
able to improve chondrogenesis based on gene expression
of cell surface receptors and effectiveness of growth
factors; withdrawal of the growth factors after nine days
improves chondrogenesis (Handorf and Li, 2014). Apart
from the addition of growth factors, inhibition of specific
cell signalling pathways may also enhance chondrogenesis,
such as the Smad1/5/8 signalling inhibitor dorsomorphin
(Hellingman et al., 2011; Retting et al., 2009) or Wnt
inhibitors [Gremlin 1, frizzled-related protein (FRP) or
dickkopf (Dkk-1)] (Leijten et al., 2012).
Use of mathematical models can assist researchers
in regulating chondrogenic differentiation. A “seesaw
model” describes a balance between mesendodermal
and ectodermal specification of pluripotency (Shu and
Deng, 2013) and the cross-talk between genetics and
epigenetics (Leijten et al., 2014). The lineage specifiers
of mesendodermal and ectodermal are considered as
pluripotency rivals. However, these lineage specifiers have
shown to facilitate reprogramming of differentiated cells
to the pluripotent state when a balance is achieved.
Summary
MSCs are a promising source of precursor cells, which are
widely used in cartilage tissue engineering. By reviewing
the process of cartilage development and the constituents of
existing medium formulations for promoting chondrogenic
differentiation, we have identified potential factors to
generate a more stable and reliable hyaline cartilage
in vitro. Cellular metabolic status, especially glucose
metabolism and inhibition of inflammatory factors, need
to be considered when trying to inhibit cell senescence
and apoptosis. The combination and concentration of
growth factors, the timing of the application of biochemical
components and proper biophysical stimuli during cell
culture needs further optimisation to achieve desirable
differentiation outcomes.
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